🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objectives of the study are to estimate the risk of major conge...
Status
Recruiting
Location
University of Colorado Anschutz Medical Campus
Start Date
2023-10-27
Trial ID
NCT05658497
Treatments Being Tested
The investigators propose a multi-center pilot study, which aims to evaluat...
Status
Active Not Recruiting
Location
University of Colorado, Denver
Start Date
2023-03-07
Trial ID
NCT07757568
The primary objective of the study is to characterize the persistence to th...
Status
Terminated
Location
Regina Berkovich MD Phd Inc
Start Date
2021-03-01
Trial ID
NCT04746976
Treatments Being Tested
In this study, researchers will learn more about the study drugs diroximel ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-11-16
Trial ID
NCT07483632
The DELIVER-MS study seeks to answer the question: Does early treatment wit...
Status
Active Not Recruiting
Location
University of Colorado-Anschutz Medical Campus
Start Date
2019-01-03
Trial ID
NCT03535298
Treatments Being Tested
FDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) tar...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2018-05-02
Trial ID
NCT03500328
Treatments Being Tested
The primary objective of the study is to characterize the persistence to th...
Status
Terminated
Location
Lady Davis Carmel Medical Center
Start Date
2021-12-09
Trial ID
NCT04948606
Treatments Being Tested
A single-dose, randomized, open-label, two-way crossover, two-period, two-s...
Status
Completed
Location
BioPharma Services, Inc.
Start Date
2021-05-14
Trial ID
NCT05181215
Treatments Being Tested
Peripheral artery disease (PAD) is associated with elevated oxidative stres...
Status
Recruiting
Location
University of Nebraska - Omaha
Start Date
2024-11-14
Trial ID
NCT06319339
In this study, researchers will learn more about the effects of diroximel f...
Status
Active Not Recruiting
Location
OptumInsight
Start Date
2021-09-24
Trial ID
NCT05688436